Pursuant to the previous research’s findings and the present investigation, we showed that Anti-miR-21 enforces anti-cancer efficacy via particular upregulation of hub genes, include CCL28, NR3C2, and SYNPO2. These results may simplify the further method for finding new therapeutic approaches in GC. The gene discussed is CCL28; the disease is gastric cancer.